THE ROLE OF THE VULVAR MICROBIOME IN THE DEVELOPMENT OF VULVAR CANCER
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstrak:
Vulvar cancer is a relatively rare gynecological malignancy; however, its incidence has shown a gradual increase, particularly among postmenopausal women. Recent advances in microbiome research have highlighted the crucial role of local microbial communities in maintaining epithelial integrity, immune regulation, and carcinogenesis. The vulvar microbiome, which consists of diverse bacterial, fungal, and viral species, plays an essential role in preserving mucosal homeostasis. Disruption of this microbial balance, known as dysbiosis, may contribute to chronic inflammation, epithelial barrier dysfunction, and altered immune responses, thereby creating a microenvironment favorable for malignant transformation.
##plugins.themes.bootstrap3.article.details##
##submission.howToCite##:
##submission.citations##:
Bodelon, C., Madeleine, M. M., Voigt, L. F., & Weiss, N. S. (2009). Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes & Control, 20(9), 1779–1782. https://doi.org/10.1007/s10552-009-9392-0
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Champer, M., Wong, A. M., Champer, J., Brito, I. L., Messer, P. W., Hou, J. Y., & Wright, J. D. (2018). The role of the vaginal microbiome in gynaecological cancer. BJOG: An International Journal of Obstetrics & Gynaecology, 125(3), 309–315. https://doi.org/10.1111/1471-0528.14631
Curty, G., Costa, R. L., Siqueira, J. D., Meyrelles, A. R., Machado, E. S., Soares, E. A., & Soares, M. A. (2019). Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions. Scientific Reports, 9, 9890. https://doi.org/10.1038/s41598-019-46342-8
Ilhan, Z. E., Łaniewski, P., Tonachio, A., Herbst-Kralovetz, M. M. (2019). Microbiota and metabolite profiles of the female genital tract: Insights into health and disease. Trends in Microbiology, 27(10), 807–820. https://doi.org/10.1016/j.tim.2019.04.005
Moyal-Barracco, M., & Leibowitch, M. (2014). Vulvar intraepithelial neoplasia. Obstetrics and Gynecology Clinics of North America, 41(2), 225–239. https://doi.org/10.1016/j.ogc.2014.02.003
Nené, N. R., Reisel, D., Leimbach, A., Franchi, D., Jones, A., Evans, I., & Mein, C. A. (2019). Association between the cervicovaginal microbiome and disease progression in women with cervical cancer. Gynecologic Oncology, 154(3), 689–695. https://doi.org/10.1016/j.ygyno.2019.06.001
Oh, J. K., Weiderpass, E., & Franceschi, S. (2014). Epidemiology of vulvar and vaginal cancers. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(1), 77–87. https://doi.org/10.1016/j.bpobgyn.2013.08.003
Schwabe, R. F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews Cancer, 13(11), 800–812. https://doi.org/10.1038/nrc3610
Shannon, B., Yi, T. J., Perusini, S., Gajer, P., Ma, B., Humphrys, M. S., & Burgener, A. D. (2017). Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunology, 10(5), 1310–1319. https://doi.org/10.1038/mi.2016.129
Witkin, S. S., Linhares, I. M., & Giraldo, P. (2007). New insights into the immune pathogenesis of bacterial vaginosis. Gynecologic and Obstetric Investigation, 63(2), 90–97. https://doi.org/10.1159/000095973